No Data
Innovative Phar (00399.HK) plans to invest in the field of AI in medical care and other areas.
Grants 12th of November: innovative phar (00399.HK) announced that on 12th November 2024, as an investor, the company has entered into a memorandum of understanding with the symbol, indicating the company's intention to invest in the potential investment of the majority of the target's equity. The target is a limited liability company registered in Delaware, USA, mainly engaged in (a) developing the ai-driven virtual health platform SyncWell, using ai applications to integrate and analyze dispersed health data, providing users with personalized real-time advice; and (b) developing innovative brain nerve technology service platform.
innovative phar (00399) is planning to acquire the majority equity of Niraxx. Inc.
Innovative Phar (00399) announced that on November 12, 2024, the company, as an investor, has already...
Express News | Innovative Pharmaceutical Biotech - to Invest in Niraxx. Inc.
Innovative phar (00399) issued 99.0099 million shares of convertible shares due to the exercise of the conversion rights of convertible bonds.
Innovative phar (00399) announced that the company, in accordance with the issuance of October 25, 2013...
Innovative Pharmaceutical Biotech Enters MOU to Develop Market for Disposable Digestive Endoscopy in China
Innovative Phar (00399) plans to establish a joint venture with Hunan Province Huaxin Medical Instruments to expand its business scope in the medical field.
Innovative Phar (00399) announced on August 26, 2024 (after trading hours), the company...
Innovative Pharmaceutical Biotech (HKG:399) Is Posting Solid Earnings, But It Is Not All Good NewsNo Data
No Data
